查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942825

2026年酵素免疫分析法全球市场报告

Enzyme Immunoassay Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，酵素免疫分析法市场呈现显着成长，预计到2025年将达到215亿美元，到2026年将达到230.9亿美元，复合年增长率为7.4%。过去几年成长要素包括：自动化EIA系统普及率有限、依赖手动微孔盘读数仪、临床检测基础设施不断扩大、慢性病和感染疾病率上升以及传统试剂和试剂盒的普及。

预计未来几年酵素免疫分析法(EIA) 市场将保持强劲成长，到 2030 年市场规模将达到 303.7 亿美元，复合年增长率 (CAGR) 为 7.1%。预测期内的成长要素包括全自动 EIA 分析仪的研发、个人化医疗和精准诊断的兴起、实验室资讯系统整合度的提高、软体和数据分析工具的广泛应用，以及学术研究机构需求的成长。预测期内的主要趋势包括：自动化 EIA 分析仪的普及率不断提高、治疗药物监测应用范围的扩大、多重和高通量检测技术的日益普及、肿瘤和传染病检查的扩展，以及对实验室数据整合和工作流程效率的日益重视。

感染疾病日益普遍预计将推动酵素免疫分析法）市场的成长。感染疾病由细菌、病毒、真菌和寄生虫等有害微生物引起，并在人与人之间传播。由于抗菌素抗药性的增加，这些疾病的负担日益加重，导致治疗复杂化、康復时间延长、医疗成本上升，最终导致更高的死亡率。酵素免疫分析法（ ELISA）是感染疾病诊断的重要工具，因为它能够以高灵敏度和特异性检测患者检体中的抗原和抗体。这使得早期诊断、有效监测和及时治疗爱滋病、肝炎和流感等疾病成为可能。例如，根据美国政府机构明尼苏达州卫生部2025年4月发布的数据，35至39岁男性中爱滋病感染者的比例预计将从2023年的10%上升到2024年的17%，证实了该年龄组的感染率显着上升。感染疾病负担的日益加重，推动了酵素免疫分析法市场的扩张。

酵素免疫分析法市场的主要企业正优先开发先进的解决方案，例如全自动酵素免疫分析法，以提高诊断准确性、减少人为误差并简化临床检查室。全自动酵素免疫分析法简化了整个检测流程，并提高了检测的速度、准确性和可靠性。例如，2024年7月，日本体外诊断试剂製造商富士瑞生物控股株式会社(Fujirebio Holdings, Inc.)推出了仅供研究使用(RUO)的全自动Lumipulse G GFAP检测，从而扩展了其神经系统生物标誌物产品线。此化学冷光酵素免疫分析法利用LUMIPULSE G平台测量人类血浆和血清中的胶质纤维酸性蛋白(GFAP)水平，可在35分钟内提供结果。 GFAP是一种星状细胞生物标记物，与多发性硬化症、阿兹海默症、帕金森氏症、中风和创伤性脑损伤等神经系统疾病有关。这项新检测方法完善了 Fujirebio 的神经退化性疾病产品组合，该产品组合已经包括 NfL、pTau217 和 sTREM2 等标誌物，支援在单一自动化平台上进行全面分析。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球酵素免疫分析法市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 自动化EIA分析仪的应用日益普及
    • 治疗药物监测（TDM）应用的成长
    • 多重检测和高通量检测技术的日益普及
    • 扩大肿瘤和传染病检查
    • 越来越重视测试数据整合和工作流程效率

第五章 终端用户产业市场分析

  • 医院
  • 临床检查室
  • 血库
  • 製药和生物技术公司
  • 学术研究机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球酵素免疫分析法市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球酵素免疫分析法市场规模、对比及成长率分析
  • 全球酵素免疫分析法市场表现：规模与成长，2020-2025年
  • 全球酵素免疫分析法市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 试剂和试剂盒、分析设备或仪器、软体和服务
  • 检体
  • 血液、唾液、尿液和其他检体
  • 透过使用
  • 治疗药物监测、肿瘤学、心臟病学、内分泌学、传染病检查、自体免疫疾病及其他应用
  • 按最终用途
  • 医院、血库、临床检查室、製药和生物技术公司、学术研究机构以及其他最终用户
  • 按类型细分：试剂和试剂盒
  • 抗体、抗原、基材、缓衝液和稳定剂
  • 按类型细分：分析仪器或设备
  • 全自动EIA分析仪、半自动EIA系统、微孔盘读数仪、洗涤设备及培养箱
  • 按类型细分：软体和服务
  • 数据分析和解释软体、实验室资讯系统整合工具、仪器校准和验证服务、技术支援和使用者培训

第十章 区域与国家分析

  • 全球酵素免疫分析法市场：按地区、表现和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球酵素免疫分析法市场：按国家、表现和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 酵素免疫分析法市场：竞争格局及市场占有率（2024年）
  • 酵素免疫分析法市场：公司估值矩阵
  • 酵素免疫分析法市场：公司概况
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories Inc.
    • Danaher Corporation
    • Merck KGaA

第37章：其他领先和创新企业

  • Siemens Healthineers AG, Becton Dickinson and Company（BD）, PerkinElmer Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Diasorin SpA, Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年酵素免疫分析法市场：提供新机会的国家
  • 2030年酵素免疫分析法市场：充满新机会的细分市场
  • 2030年酵素免疫分析法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MEIMM01_G26Q1

Enzyme immunoassay is a highly sensitive laboratory technique that utilizes antibodies conjugated with enzymes to specifically identify and quantify target molecules such as proteins, hormones, or infectious agents within a sample. The method is based on an enzymatic reaction that generates a detectable signal-often a color change-which correlates directly with the concentration of the analyte, enabling accurate diagnostic or research analysis.

The primary product types in enzyme immunoassay include reagents and kits, analyzers or instruments, and software and services. Reagents and kits consist of chemical substances or pre-packaged sets of chemicals used in laboratory and clinical testing to detect, measure, or process other substances. These products accommodate various specimen types, such as blood, saliva, urine, and others, and support a wide array of applications, including therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease detection, autoimmune disease testing, and more. They serve a broad range of end users, including hospitals, blood banks, clinical laboratories, pharmaceutical and biotechnology companies, academic research centers, and other institutions.

Tariffs are impacting the enzyme immunoassay market by increasing costs of imported reagents, kits, and analyzers, impacting production and procurement expenses. Segments such as fully automated analyzers and specialized reagents are most affected, particularly in Asia-Pacific regions like China and India, which serve as major manufacturing hubs. While tariffs have introduced supply chain challenges and price pressures, they have also encouraged local manufacturing, innovation in assay kits, and development of domestic production capabilities.

The enzyme immunoassay market research report is one of a series of new reports from The Business Research Company that provides enzyme immunoassay market statistics, including enzyme immunoassay industry global market size, regional shares, competitors with a enzyme immunoassay market share, detailed enzyme immunoassay market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme immunoassay industry. This enzyme immunoassay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enzyme immunoassay market size has grown strongly in recent years. It will grow from $21.5 billion in 2025 to $23.09 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to limited availability of automated eia systems, reliance on manual microplate readers, growing clinical laboratory infrastructure, increasing prevalence of chronic and infectious diseases, adoption of conventional reagents and kits.

The enzyme immunoassay market size is expected to see strong growth in the next few years. It will grow to $30.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to development of fully automated eia analyzers, expansion of personalized medicine and precision diagnostics, increasing integration of laboratory information systems, rising adoption of software and data analysis tools, growing demand from academic and research institutions. Major trends in the forecast period include rising adoption of automated eia analyzers, growth in therapeutic drug monitoring applications, increasing use of multiplex testing and high-throughput assays, expansion of oncology and infectious disease testing, enhanced focus on laboratory data integration and workflow efficiency.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the enzyme immunoassay market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can be transmitted between individuals. The burden of these diseases is growing due to rising antimicrobial resistance, which complicates treatment, extends recovery times, raises healthcare costs, and leads to increased mortality. Enzyme immunoassays are essential tools for diagnosing infectious diseases, offering sensitive and specific detection of antigens or antibodies in patient samples. This facilitates early diagnosis, effective monitoring, and timely treatment for conditions such as HIV, hepatitis, and influenza. For example, in April 2025, the Minnesota Department of Health, a US-based government agency, reported that the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, reflecting a significant rise in this demographic. As a result, the increasing burden of infectious diseases is contributing to the expansion of the enzyme immunoassay market.

Leading companies in the enzyme immunoassay market are prioritizing the development of advanced solutions, such as fully automated enzyme immunoassays, to boost diagnostic accuracy, reduce human error, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays streamline the entire testing process, enhancing the speed, precision, and reliability of laboratory diagnostics. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics company, introduced the fully automated Lumipulse G GFAP assay for research use only (RUO), expanding its neuro-biomarker product line. This chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) levels in human plasma and serum using the LUMIPULSE G platform, delivering results within 35 minutes. GFAP is an astrocytic biomarker associated with neurological conditions such as multiple sclerosis, Alzheimer's and Parkinson's diseases, stroke, and traumatic brain injury. This new assay complements Fujirebio's neurodegenerative disease portfolio, which already includes markers like NfL, pTau217, and sTREM2, supporting comprehensive profiling on a single automated platform.

In January 2025, Medix Biochemica, a Finland-based supplier of raw materials for in vitro diagnostics, acquired CANDOR Bioscience GmbH for an undisclosed sum. This acquisition is aimed at strengthening Medix Biochemica's position as a leading global provider in the IVD industry by expanding its portfolio with CANDOR's specialized expertise in high-performance blockers and assay optimization reagents. These technologies support improved performance in enzyme immunoassays and enable more robust diagnostic test development. CANDOR Bioscience GmbH is a Germany-based biotechnology company that focuses on optimizing immunoassay systems, including enzyme immunoassays and ELISA development.

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enzyme immunoassay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The enzyme immunoassay market consists of sales of enzyme-labeled antibodies, sample diluents, blocking reagents, microplate readers, ELISA test kits, robotic liquid handling systems, and plate washers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Enzyme Immunoassay Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses enzyme immunoassay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for enzyme immunoassay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enzyme immunoassay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Analyzers Or Instruments; Software And Services
  • 2) By Specimen: Blood; Saliva; Urine; Other Specimens
  • 3) By Application: Therapeutic Drug Monitoring; Oncology; Cardiology; Endocrinology; Infectious Disease Testing; Autoimmune Diseases; Other Applications
  • 4) By End-Use: Hospitals; Blood Banks; Clinical Laboratories; Pharmaceutical And Biotech Companies; Academic Research Centers; Other End-Uses
  • Subsegments:
  • 1) By Reagents And Kits: Antibodies; Antigens; Substrates; Buffers And Stabilizers
  • 2) By Analyzers Or Instruments: Fully Automated EIA Analyzers; Semi-Automated EIA Systems; Microplate Readers; Washers And Incubators
  • 3) By Software And Services: Data Analysis And Interpretation Software; Laboratory Information System Integration Tools; Instrument Calibration And Validation Services; Technical Support And User Training
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG; Becton Dickinson and Company (BD); PerkinElmer Inc.; BioMerieux SA; Bio-Rad Laboratories Inc.; Diasorin S.p.A.; Bio-Techne Corporation; Quidel Corporation; Promega Corporation; Abcam plc; BioLegend Inc.; Helena Laboratories Corporation; Cayman Chemical Company; Enzo Life Sciences Inc.; RayBiotech Inc.; MyBioSource Inc.; Boster Biological Technology; Hycult Biotech; Calbiotech Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Enzyme Immunoassay Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Enzyme Immunoassay Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Enzyme Immunoassay Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Enzyme Immunoassay Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Automated Eia Analyzers
    • 4.2.2 Growth In Therapeutic Drug Monitoring Applications
    • 4.2.3 Increasing Use Of Multiplex Testing And High-Throughput Assays
    • 4.2.4 Expansion Of Oncology And Infectious Disease Testing
    • 4.2.5 Enhanced Focus On Laboratory Data Integration And Workflow Efficiency

5. Enzyme Immunoassay Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Blood Banks
  • 5.4 Pharmaceutical And Biotech Companies
  • 5.5 Academic Research Centers

6. Enzyme Immunoassay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Enzyme Immunoassay Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Enzyme Immunoassay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Enzyme Immunoassay Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Enzyme Immunoassay Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Enzyme Immunoassay Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Enzyme Immunoassay Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Enzyme Immunoassay Market Segmentation

  • 9.1. Global Enzyme Immunoassay Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Analyzers Or Instruments, Software And Services
  • 9.2. Global Enzyme Immunoassay Market, Segmentation By Specimen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood, Saliva, Urine, Other Specimens
  • 9.3. Global Enzyme Immunoassay Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
  • 9.4. Global Enzyme Immunoassay Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses
  • 9.5. Global Enzyme Immunoassay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibodies, Antigens, Substrates, Buffers And Stabilizers
  • 9.6. Global Enzyme Immunoassay Market, Sub-Segmentation Of Analyzers Or Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators
  • 9.7. Global Enzyme Immunoassay Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

10. Enzyme Immunoassay Market Regional And Country Analysis

  • 10.1. Global Enzyme Immunoassay Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Enzyme Immunoassay Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Enzyme Immunoassay Market

  • 11.1. Asia-Pacific Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Enzyme Immunoassay Market

  • 12.1. China Enzyme Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Enzyme Immunoassay Market

  • 13.1. India Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Enzyme Immunoassay Market

  • 14.1. Japan Enzyme Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Enzyme Immunoassay Market

  • 15.1. Australia Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Enzyme Immunoassay Market

  • 16.1. Indonesia Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Enzyme Immunoassay Market

  • 17.1. South Korea Enzyme Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Enzyme Immunoassay Market

  • 18.1. Taiwan Enzyme Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Enzyme Immunoassay Market

  • 19.1. South East Asia Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Enzyme Immunoassay Market

  • 20.1. Western Europe Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Enzyme Immunoassay Market

  • 21.1. UK Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Enzyme Immunoassay Market

  • 22.1. Germany Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Enzyme Immunoassay Market

  • 23.1. France Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Enzyme Immunoassay Market

  • 24.1. Italy Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Enzyme Immunoassay Market

  • 25.1. Spain Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Enzyme Immunoassay Market

  • 26.1. Eastern Europe Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Enzyme Immunoassay Market

  • 27.1. Russia Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Enzyme Immunoassay Market

  • 28.1. North America Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Enzyme Immunoassay Market

  • 29.1. USA Enzyme Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Enzyme Immunoassay Market

  • 30.1. Canada Enzyme Immunoassay Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Enzyme Immunoassay Market

  • 31.1. South America Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Enzyme Immunoassay Market

  • 32.1. Brazil Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Enzyme Immunoassay Market

  • 33.1. Middle East Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Enzyme Immunoassay Market

  • 34.1. Africa Enzyme Immunoassay Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Enzyme Immunoassay Market, Segmentation By Product, Segmentation By Specimen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Enzyme Immunoassay Market Regulatory and Investment Landscape

36. Enzyme Immunoassay Market Competitive Landscape And Company Profiles

  • 36.1. Enzyme Immunoassay Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Enzyme Immunoassay Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Enzyme Immunoassay Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Enzyme Immunoassay Market Other Major And Innovative Companies

  • Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc.

38. Global Enzyme Immunoassay Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Enzyme Immunoassay Market

40. Enzyme Immunoassay Market High Potential Countries, Segments and Strategies

  • 40.1 Enzyme Immunoassay Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Enzyme Immunoassay Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Enzyme Immunoassay Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer